Literature DB >> 6280044

Giant axonal neuropathy: an inborn error of organization of intermediate filaments.

S D Pena.   

Abstract

Light microscopic examination of cultured skin fibroblasts from three patients with giant axonal neuropathy (GAN) revealed large aggregates of intermediate filaments (IF). However, electrophoretic analysis of these cells showed normal amounts of vimentin, the fibroblast IF subunit protein. The isoelectric point and peptide mapping of vimentin were identical to controls. Moreover, vimentin was synthesized and phosphorylated at a normal rate. These findings demonstrate that GAN is an inborn error of the organization of IF and suggest that the basic genetic defect in GAN does not involve primarily the IF subunit proteins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280044     DOI: 10.1002/mus.880050215

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Intermediate filament protein accumulation in motor neurons derived from giant axonal neuropathy iPSCs rescued by restoration of gigaxonin.

Authors:  Bethany L Johnson-Kerner; Faizzan S Ahmad; Alejandro Garcia Diaz; John Palmer Greene; Steven J Gray; Richard Jude Samulski; Wendy K Chung; Rudy Van Coster; Paul Maertens; Scott A Noggle; Christopher E Henderson; Hynek Wichterle
Journal:  Hum Mol Genet       Date:  2014-11-04       Impact factor: 6.150

2.  Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro.

Authors:  G Moretto; S Monaco; M G Passarin; M D Benedetti; N Rizzuto
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Giant axonal neuropathy. A neuropathological study.

Authors:  H A Kretzschmar; B O Berg; R L Davis
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  The surface glycoproteins of human skin fibroblasts detected after electrophoresis by the binding of peanut (Arachis hypogaea) agglutinin and Ricinus communis (castor-bean) agglutinin I.

Authors:  B B Gordon; S D Pena
Journal:  Biochem J       Date:  1982-11-15       Impact factor: 3.857

5.  Intermediate filament aggregates cause mitochondrial dysmotility and increase energy demands in giant axonal neuropathy.

Authors:  Eitan Israeli; Dilyan I Dryanovski; Paul T Schumacker; Navdeep S Chandel; Jeffrey D Singer; Jean P Julien; Robert D Goldman; Puneet Opal
Journal:  Hum Mol Genet       Date:  2016-03-21       Impact factor: 6.150

6.  A requirement for cytoplasmic dynein and dynactin in intermediate filament network assembly and organization.

Authors:  Brian T Helfand; Atsushi Mikami; Richard B Vallee; Robert D Goldman
Journal:  J Cell Biol       Date:  2002-05-28       Impact factor: 10.539

7.  Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.

Authors:  Bethany L Johnson-Kerner; Alejandro Garcia Diaz; Sean Ekins; Hynek Wichterle
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

8.  New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy.

Authors:  Henry Houlden; Mike Groves; Zosia Miedzybrodzka; Helen Roper; Tracey Willis; John Winer; Gaynor Cole; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-19       Impact factor: 10.154

9.  Giant axonal neuropathy: a conditional mutation affecting cytoskeletal organization.

Authors:  M W Klymkowsky; D J Plummer
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.